Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO0683
Host Cell : Nme Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO0683 |
| Description | This cell line is engineered to stably co-overexpress EGFP and human HRAS bearing G12V mutation. |
| Target Gene | HRAS-G12V/EGFP |
| Gene Species | Homo sapiens (Human) |
| Host Cell | Nme |
| Applications |
1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Disease research |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
The Human HRAS-G12V/EGFP Stable Cell Line is a cell line that has been engineered to express a mutated form of the HRAS gene, specifically the G12V mutation, fused with the EGFP (enhanced green fluorescent protein). HRAS is a small GTPase that is involved in cell growth, differentiation, and survival. Mutations in HRAS, such as the G12V mutation, are commonly found in various cancers and are associated with constitutive activation of the protein, leading to uncontrolled cell proliferation. The inclusion of EGFP allows for the visualization of cells expressing the HRAS mutation, which is useful for studying the effects of this mutation on cell behavior and for screening potential therapeutic agents. This cell line is particularly valuable for research into the mechanisms of HRAS-mediated transformation and for the development of targeted therapies against HRAS-driven cancers.
The Human HRAS-G12V/EGFP Stable Cell Line - Nme is a specialized tool for studying the effects of the HRAS G12V mutation, which is commonly associated with cancer. This cell line has several unique applications:
(1) Cancer Biology Research: The G12V mutation in HRAS leads to constitutive activation of the protein, promoting uncontrolled cell growth. This cell line allows researchers to study the cellular changes induced by this mutation, including alterations in cell cycle regulation and signal transduction pathways.
(2) Drug Discovery: The EGFP tag in this cell line enables the visualization of cells expressing the mutant HRAS. This feature can be leveraged for high-throughput screening of compounds that may inhibit HRAS activity or reverse its oncogenic effects, aiding in the discovery of new cancer treatments.
(3) Mechanism of Action Studies: By expressing the HRAS G12V mutation, this cell line can be used to investigate the molecular mechanisms by which HRAS mutations contribute to cancer development and progression. This includes studying the interaction of HRAS with other proteins and the downstream effects on gene expression and cellular behavior.
A: This cell line, by expressing the HRAS gene with the G12V mutation, helps researchers observe how this mutation affects intracellular signaling pathways, particularly those related to cell proliferation and survival, such as the MAPK and PI3K/AKT/mTOR pathways.
A: By monitoring the fluorescence intensity of EGFP, researchers can evaluate the effects of drugs on the activity of HRAS G12V mutant cells, thus screening for candidate drugs that may inhibit or activate the HRAS signaling pathway.
A: This cell line provides a model for studying how HRAS G12V mutations promote the occurrence and development of cancer, including the proliferation, invasion, and metastasis of tumor cells.
A: By analyzing the cell cycle distribution of EGFP-tagged HRAS G12V cells, researchers can understand how HRAS mutations affect the cell cycle progression, especially at the G1/S and G2/M checkpoints.
A: By observing the phenotypic changes of HRAS G12V mutant cells treated with specific differentiation inducers, researchers can explore how HRAS mutations affect the differentiation potential of cells.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
The Human HRAS-G12V/EGFP Stable Cell Line - Nme provides a model for studying the effects of the HRAS G12V mutation on cell functions.
The EGFP tag allows researchers to observe the expression and localization of the HRAS G12V protein in real-time within cells.
This cell line serves as a powerful tool for studying the role of HRAS mutations in cancer development.
Aids in studying how the HRAS G12V mutation affects intracellular signaling pathways.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.